Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05864794

Value of Screening MRI Brain in Stage IV Non-small Cell Lung Cancer

ValUe of Screening MRI Brain in Patients With Newly Diagnosed Stage IV Non-oncogene Addicted Non-small Cell Lung CANcer - The VULCAN Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
University Medical Center Groningen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients with newly diagnosed stage IV non-oncogene addicted NSCLC, who are fit for systemic treatment and don't have any symptoms of brain disease will undergo an MRI of the brain to screen for brain disease.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMRIMRI scan of the brain

Timeline

Start date
2024-05-13
Primary completion
2025-09-01
Completion
2026-07-01
First posted
2023-05-18
Last updated
2024-05-23

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT05864794. Inclusion in this directory is not an endorsement.

Value of Screening MRI Brain in Stage IV Non-small Cell Lung Cancer (NCT05864794) · Clinical Trials Directory